MDxHealth (MDXH) Non-Current Deferred Tax Liability (2022 - 2025)

MDxHealth (MDXH) posted Non-Current Deferred Tax Liability of $1.6 million for Q4 2025, down 99.9% sequentially from $1.6 billion in Q2 2025.

MDxHealth (MDXH) Non-Current Deferred Tax Liability (2022 - 2025) Analysis & Trends

MDxHealth has reported Non-Current Deferred Tax Liability for 2 years, with the latest figure at $1.6 million in Q4 2025.

Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 million (changed N/A YoY) and the FY2025 annual result came in at $1.6 million, changed N/A from the prior year.
Non-Current Deferred Tax Liability retreated to $1.6 million in Q4 2025 per MDXH's latest filing, from $1.6 billion in the prior quarter.
Over five years, Non-Current Deferred Tax Liability peaked at $1.6 billion in Q2 2025 and troughed at $129000.0 in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn
10	MDxHealth	21.81 Mn	-21.34 Mn	16.61 Mn

Download Data